Giananthony Rizzo[email protected]Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 2In the second part of our series on the coming shortage of SPECT radiopharmaceuticals, Giananthony Rizzo of Decision Resources Group examines other factors in the U.S. healthcare industry that could affect isotope prices in the future.November 17, 2016Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 1A perfect storm is brewing in the global SPECT market that could see the prices of radiopharmaceuticals skyrocket over the next five years. A number of factors are coalescing that could lead to a shortage of SPECT tracers for years to come, according to this article by Giananthony Rizzo of Decision Resources Group.November 16, 2016Page 1 of 1Top StoriesRSNA 2025Studies reveal trends in breast density, cancer in younger womenStamatia Destounis, MD, presented multiple breast imaging studies at RSNA 2025 on breast density and cancer incidence.HomeHow best can radiology departments reduce patient no-shows?RSNA 2025Ultrasound finds complications from cosmetic fillersRSNA 2025Stent procedure safe in pediatric liver transplant patientsRSNA 2025Using AI with CT to assess epicardial fat predicts heart disease risk